Analyst Price Target is $137.67
▼ -8.44% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Hill-Rom in the last 3 months. The average price target is $137.67, with a high forecast of $156.00 and a low forecast of $117.00. The average price target represents a -8.44% upside from the last price of $150.36.
Current Consensus is
The current consensus among 6 investment analysts is to hold stock in Hill-Rom. This rating has held steady since August 2020, when it changed from a Buy consensus rating.
Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.